Can treatment of subclinical hypothyroidism help diminish frequency and severity of migraines? This study suggests that levothyroxine can do both.
Which antiepileptic drugs work best as monotherapy? A new Cochrane meta-analysis scrutinizes the evidence.
A study that compared motor and nonmotor outcomes of DBS for Parkinson disease may show promise for patients' quality of life.
Can aspirin improve exercise endurance in people with MS? How best to treat children with MOG-Ab associated disease? What factors increase MS susceptibility?
Here's reason to start eslicarbazepine acetate at 400 mg daily.
A new study finds that children with epilepsy who are treated with antiepileptic drugs sustain more bone fractures than kids who don't take these drugs. Details here.
Clinically useful Insights on multiple sclerosis culled from 3 presentations at the 7th Joint ECTRIMS-ACTRIMS conference are briefly summarized here.
Your patient has CAD and migraine and is taking Paxil for depression. Can he take a triptan?
What does epigenetics have to do with risk for Alzheimer disease? Are our epigenetics immutable? What are the therapeutic implications? Those questions answered in this podcast.
A new study is the first to assess the relationship between lithium in drinking water and incidence of dementia.
Migraine—especially migraine with aura—is a CV risk factor, which makes the prescription of ergots or triptans potentially problematic. What’s the best approach?
Three new things about multiple sclerosis presented at ECTRIMS 2017 are highlighted in this slideshow.
A new study with longitudinal follow-up looked at disability trajectories after stroke compared with myocardial infarction.
A study of over 80,000 patients confirmed another strong reason to prevent young people from repetitive head blows.
Most neurologists reach for levetiracetam monotherapy for children with early onset, nonsyndromic epilepsy initially. This study questions that practice.